Translational Development Acquisition (TDACU) Non Operating Income (2024 - 2026)

Translational Development Acquisition has reported Non Operating Income for 3 years, with the latest figure at $1.6 million in Q1 2026.

• For the quarter ending Q1 2026, Non Operating Income fell 11.83% year-over-year to $1.6 million; the trailing twelve-month figure through Mar 2026 stood at $7.1 million (up 262.53% YoY), and the FY2025 full-year result was $7.3 million, up 5729.44% from the prior year.
• Non Operating Income for Q1 2026 stood at $1.6 million, down from $1.8 million in the prior quarter.
• The five-year high for Non Operating Income was $1.9 million in Q3 2025, with the low at $125346.0 in Q4 2024.
• Historically, Non Operating Income has averaged $1.5 million across 3 years, with a median of $1.8 million in 2025.
• Annual changes were most pronounced in 2025 — Non Operating Income soared 1302.7% — and 2026, when it fell 11.83%.
• Translational Development Acquisition's Non Operating Income stood at $125346.0 in 2024, then soared by 1302.7% to $1.8 million in 2025, then declined by 8.21% to $1.6 million in 2026.
• The last three Non Operating Income figures came in at $1.6 million (Q1 2026), $1.8 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.